• Corpus ID: 25931991

Mifepristone in South Australia -- the first 1343 tablets.

  title={Mifepristone in South Australia -- the first 1343 tablets.},
  author={Ea C Mulligan and Hayley Messenger},
  journal={Australian family physician},
  volume={40 5},
          342-5; quiz 351-2
BACKGROUND Mifepristone has recently become available in Australia but its use is restricted. OBJECTIVE To describe the use of mifepristone in South Australia in the period 2009-2010 and to explore options that may become available to general practitioners. DISCUSSION Mifepristone has been added to regimens for early and second trimester abortions - both medical and surgical abortions. It has been most commonly used in early medical abortions. In this audit the complication rates of early… 
The use of mifepristone for medical abortion.
  • Medicine
    The Australian & New Zealand journal of obstetrics & gynaecology
  • 2019
This statement is intended to provide advice on the use of mifepristone for medical abortion to health professionals providing gynaecological care, and patients.
Early medical abortion — available and safe
The results, and those published by others, show that mifepristone–misoprostol home abortion is safe, effective and acceptable to Australian women, and mifEPristone can be safely used for EMA by any appropriately trained doctor in Australia.
Medical abortion: the Australian experience
The political and legal aspects of medicalabortion are integral to an account of the experience of medical abortion in Australia, and will therefore be discussed in this article together with all other articles on the subject.
Early medical abortion using low‐dose mifepristone followed by buccal misoprostol: a large Australian observational study
The use of mifepristone in combination with buccal misoprostol in women undergoing an early medical abortion (EMA) in Australia is described.
Off-label use of misoprostol in gynaecology
There is good clinical evidence for efficacy and safety of misoprostol in uterine evacuation in both miscarriage and termination of pregnancy and the clinician must also be careful to use an evidence-based protocol that would withstand medicolegal challenge in the case of an adverse outcome.
Effectiveness of early medical abortion using low-dose mifepristone and buccal misoprostol in women with no defined intrauterine gestational sac.
EMA failure is more likely in women with early pregnancy and no defined IUGS than those with gestations ≤ 63 days and confirmed IUGs.
Medical abortion in Australia: a short history
  • B. Baird
  • Medicine
    Reproductive health matters
  • 2015
The integration of medical abortion into primary health care, which would locate abortion provision in new settings and expand women’s access, has been constrained by the stigma attached to abortion, overly cautious institutionalised frameworks, and the lack of public health responsibility for abortion services.
Medical and Surgical Induced Abortion
No method of contraception is 100% effective; over half the women seeking an abortion are using contraception, and half of these are illegal and unsafe.
Knowledge of abortion law and provision of abortion services amongst tertiary students in Far North Queensland
A survey of tertiary students in Far North Queensland to ascertain their knowledge of local abortion services and of abortion law in Queensland found important gaps were demonstrated in students' knowledge of the law and of the availability of abortion services.
Making it legal: Abortion providers' knowledge and use of abortion law in New South Wales and Queensland
To explore the knowledge of state abortion law of doctors providing abortion in New South Wales and Queensland, their attitudes towards this law, and their application of both knowledge and attitudes


Medical abortion for Australian women: it's time.
Medical termination of pregnancy with mifepristone, a progesterone antagonist, is available to women in North America, the United Kingdom, much of Western Europe, Russia, China, Israel, New
Early medical abortion: legal and medical developments in Australia
  • K. Petersen
  • Medicine
    The Medical journal of Australia
  • 2010
The decriminalisation of abortion in all Australian jurisdictions would protect medical practitioners from criminal liability, promote the health interests of Australian women, and discourage the illegal importation of abortifacients that are being used without quality controls or medical supervision.
A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.
Simultaneous use of mifepristone and misoprostol for second trimester medical abortion is not as effective as the regimen using a 36-38 h dosing interval.
Medical methods for first trimester abortion.
Different medical methods used for first trimester abortion, compared with each other or placebo were included and the outcomes sought include mortality, failure to achieve complete abortion, surgical evacuation, ongoing pregnancy at follow-up, and more frequent side effects such as nausea and diarrhoea.
Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: Worth the effort
Objective:  To determine the impact on the process of second trimester medical termination for fetal abnormality following the introduction of adjunctive mifepristone in an Australian tertiary
Autopsy after termination of pregnancy for fetal anomaly: retrospective cohort study
There has been an increase in the rate of terminations of pregnancy for fetal anomaly and there has been a decline in the autopsy rate, when a prenatal diagnosis was based on the results of a scan only, and the addition of information from an autopsy by a specialist paediatric pathologist provided important information that changed the estimated risk of recurrence.